SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001104659-24-019936
Filing Date
2024-02-13
Accepted
2024-02-13 16:30:14
Documents
4
Period of Report
2024-03-29

Document Format Files

Seq Description Document Type Size
1 PRE 14A tm246018d1_pre14a.htm PRE 14A 105971
2 GRAPHIC image_001.jpg GRAPHIC 4145
3 GRAPHIC tm246018d1_pre14aimg001.jpg GRAPHIC 89215
4 GRAPHIC tm246018d1_pre14aimg002.jpg GRAPHIC 106055
  Complete submission text file 0001104659-24-019936.txt   382295
Mailing Address 23 HATA'AS STREET KFAR SABA L3 44425
Business Address 23 HATA'AS STREET KFAR SABA L3 44425 97299741444
Quoin Pharmaceuticals, Ltd. (Filer) CIK: 0001671502 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3
Type: PRE 14A | Act: 34 | File No.: 001-37846 | Film No.: 24626540
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)